The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
Abstract
Associations between modifiable exposures and disease seen in observational epidemiology are sometimes confounded and thus misleading, despite our best efforts to improve the design and analysis of studies. Mendelian randomization—the random assortment of genes from parents to offspring that occurs during gamete formation and conception—provides one method for assessing the causal nature of some environmental exposures. The association between a disease and a polymorphism that mimics the biological link between a proposed exposure and disease is not generally susceptible to the reverse causation or confounding that may distort interpretations of conventional observational studies. Several examples where the phenotypic effects of polymorphisms are well documented provide encouraging evidence of the explanatory power of Mendelian randomization and are described. The limitations of the approach include confounding by polymorphisms in linkage disequilibrium with the polymorphism under study, that polymorphisms may have several phenotypic effects associated with disease, the lack of suitable polymorphisms for studying modifiable exposures of interest, and canalization—the buffering of the effects of genetic variation during development. Nevertheless, Mendelian randomization provides new opportunities to test causality and demonstrates how investment in the human genome project may contribute to understanding and preventing the adverse effects on human health of modifiable exposures. Genetic epidemiology—the theme of this issue of the International Journal of Epidemiology—is seen by many to be the only future for epidemiology, perhaps reflecting a growing awareness of the limitations of observational epidemiology1 (Box 1). Genetic epidemiology is concerned with understanding heritable aspects of disease risk, individual susceptibility to disease, and ultimately with contributing to a comprehensive molecular understanding of pathogenesis. The massive investment and expansion of human genetics, if it is to return value for the common good, must be integrated into public health functions. The human genome epidemiology network (HuGE Net—http://www.cdc.gov/genetics/huge.htm) has been established to promote the use of genetic knowledge—in terms of genetic tests and services—for disease prevention and health promotion.2,3 A broad taxonomy of human genome studies of public health relevance has been developed4 (Box 2). In this issue of the IJE, we publish a paper by Miguel Porta,5 who highlights the need for a more rational approach to genetic testing, given the likely low penetrance of many genes associated with cancers,6 likening the role of the genome to a jazz score that is interpreted and developed through experience and context—and is seldom predictable. Such insights may well temper enthusiasm for genetic testing in populations. However, in parallel to the approaches advocated by HuGE, genetic epidemiology can lead to a more robust understanding of environmental determinants of disease (e.g. dietary factors, occupational exposures, and health-related behaviours) relevant to whole populations (and not simply to genetically susceptible sub-populations).7–10 This approach has recently been referred to as ‘Mendelian randomization’.11–15 Here we begin by briefly reviewing reasons for current concerns about aetiological findings generated by conventional observational epidemiology and then we outline the potential contribution (and limitations) of Mendelian randomization. ‘Epidemiology set to get fast-track treatment’ ‘A consortium of leading European research centres and pharmaceutical companies will this week announce a plan to transform epidemiology by combining it with the new techniques of high-throughput biology. They plan to create a new field of study—genomic epidemiology—by using screening technologies derived from the human genome project … We think it is important to expand classical epidemiology and genetic epidemiology to take it to this high-throughput mode, says Esper Boel, vice-president of biotechnology research at Novo Nordisk. We want to use post-genomic technologies to create a new clinical science, to turn functional genomics into real clinical chemistry.’ From: Butler D. Epidemiology set to get fast-track treatment. Nature 2001;414:139. Reprinted with permission. Surveillance Population frequency of gene variants predisposing to specific diseases Population frequency of morbidity and mortality from such diseases Population frequency and effects of environmental factors known to interact with gene variants Economic costs of genetic components of diseases Coverage, access, and uptake of genetic tests and services Aetiology Magnitude of disease risk associated with gene variants in different populations Contribution of gene variants to the overall level of disease in different populations Magnitude of disease risk associated with gene–gene and gene–environment interactions in different populations Heal
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The essence of an MR design is that the association between a genetic variant (G) and an outcome (Y) can be used to test whether and by how much the exposure of interest (X) influences the outcome, provided that the genetic variant is associated with the exposure of interest and has no other source of association with the outcome.1,9”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“When initially presented, it was concluded that “[MR] offers a more robust approach to understanding the effect of some modifiable exposures on health outcomes than does much conventional observational epidemiology”1 and that where possible, RCTs should follow to establish the effects of interventions. This conclusion remains unchanged, although moving towards formal triangulation of all pertinent”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Canalization can occur when polymorphic phenotypes expressed during fetal development lead to the development of compensating pathways to mitigate the effects of that expression. 1,178,179”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Estimating effect sizes through the instrumental variable approach imposes a fourth assumption, usually homogeneity of effects of the exposure on the outcome.16 58 59 60”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Most MR studies rely on three core IV assumptions (relevance, independence, and exclusion restriction; fig 1, box 3) to carry out testing for causal effects of the exposure on the outcome.16”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Similarly, violation of the ‘exclusion restriction criteria’33–37 could bias causal estimates in IV analyses when used to test effects of intermediates in RCTs or when used in observational data (including MR)”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“but may be confounded by population stratification.33,34”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“Human genetics can provide compelling evidence of causation through approaches such as Mendelian randomization (MR).”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Performed well, such studies called Mendelian randomization (MR) analyses, can provide rigorous evidence of causation 9,10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“We can exploit the properties of the human genome (specifically, the random segregation of alleles and their non-modifiable nature) to make causal inferences about the relationships between risk factors and disease 10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Mendelian randomization uses genetic variants, assumed to be instrumental variables for a particular exposure, to estimate the causal effect of that exposure on an outcome.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
In the citing paper
“If the instrumental variable criteria are satisfied, the resulting estimator is consistent even in the presence of unmeasured confounding and reverse causation.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Spielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,679
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
CANALIZATION OF DEVELOPMENT AND THE INHERITANCE OF ACQUIRED CHARACTERS
WADDINGTON, C. H. (1942) · Nature · doi:10.1038/150563a0 · Cited by 3,255
Research works printed but not linked: 3
- Skrabanek P. False Premises, False Promises. Whithorn: Tarragon Press, 2000.
- http://www.ncbi.nlm.nih.gov/Omim (accessed 12 Dec 2002).
- Heart Protection Study Collaborative Group. MRC/BHF heart protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals. Lancet2002;360:7–22. · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 1,037
A Retrospective on Fundamental Cause Theory: State of the Literature and Goals for the Future
Clouston, S., & Link, B. G. (2021) · Annual Review of Sociology · doi:10.1146/annurev-soc-090320-094912 · Cited by 206
Burgess, S., Zuber, V., Valdés‐Márquez, E., Sun, B. B., & Hopewell, J. C. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22077 · Cited by 196
The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis
Fall, T., Hägg, S., Mägi, R., Ploner, A., Fischer, K., Horikoshi, M., Sarin, A.-P., Thorleifsson, G., Ladenvall, C., Kals, M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001474 · Cited by 203
Østergaard, S. D., Mukherjee, S., Sharp, S. J., Proitsi, P., Lotta, L. A., Day, F., Perry, J. R. B., Boehme, K. L., Walter, S., Kauwe, J. S., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001841 · Cited by 203
Rosoff, D. B., Smith, G. D., Mehta, N. N., Clarke, T., & Lohoff, F. W. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003410 · Cited by 213
Burgess, S., Thompson, D. J., Rees, J. M. B., Day, F. R., Perry, J. R., & Ong, K. K. (2017) · Genetics · doi:10.1534/genetics.117.300191 · Cited by 197
Big data hurdles in precision medicine and precision public health
Prosperi, M., Min, J. S., Bian, J., & Modave, F. (2018) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-018-0719-2 · Cited by 200
Richardson, T. G., Harrison, S., Hemani, G., & Davey Smith, G. (2019) · eLife · doi:10.7554/elife.43657 · Cited by 198
Alcohol Consumption and Risk for Coronary Heart Disease in Men With Healthy Lifestyles
Mukamal, K. J., Chiuve, S. E., & Rimm, E. B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2145 · Cited by 197
Obstacles and opportunities in meta-analysis of genetic association studies
Salanti, G., Sanderson, S., & Higgins, J. P. T. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000151839.12032.1a · Cited by 196
Pleiotropy robust methods for multivariable Mendelian randomization
Grant, A. J., & Burgess, S. (2021) · Statistics in Medicine · doi:10.1002/sim.9156 · Cited by 194
Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review
Raeini, A. G., Ghaderi, A., Sharafi, A., Nematollahi, B., Moossavi, M., Derakhshani, A., & Sarab, G. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.950465 · Cited by 232
Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?
Yarmolinsky, J., Wade, K. H., Richmond, R. C., Langdon, R., Bull, C. J., Tilling, K. M., Relton, C. L., Lewis, S. J., Smith, G. D., & Martin, R. M. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-1177 · Cited by 189
Sun, Y.-Q., Burgess, S., Staley, J. R., Wood, A. M., Bell, S., Kaptoge, S. K., Guo, Q., Bolton, T. R., Mason, A. M., Butterworth, A. S., et al. (2019) · BMJ · doi:10.1136/bmj.l1042 · Cited by 193
Gene-centric Association Signals for Lipids and Apolipoproteins Identified via the HumanCVD BeadChip
Talmud, P. J., Drenos, F., Shah, S. H., Shah, T., Palmen, J., Verzilli, C. J., Gaunt, T. R., Pallas, J. A., Lovering, R. C., Li, K., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.10.014 · Cited by 194
Self-citationKamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.248765 · Cited by 193
Gamma‐glutamyltransferase—friend or foe within?
Kunutsor, S. K. (2016) · Liver International · doi:10.1111/liv.13221 · Cited by 203
Zhu, X., Bai, W.-Y., & Zheng, H. (2021) · Bone Research · doi:10.1038/s41413-021-00143-3 · Cited by 203
Taylor, A. E., Jones, H. J., Sallis, H., Euesden, J., Stergiakouli, E., Davies, N. M., Zammit, S., Lawlor, D. A., Munafò, M. R., Davey Smith, G., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy060 · Cited by 192
A Mendelian randomization study of the effects of blood lipids on breast cancer risk
Nowak, C., & Ärnlöv, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06467-9 · Cited by 193
Mendelian Randomization for Strengthening Causal Inference in Observational Studies
Smith, G. D. (2010) · Perspectives on Psychological Science · doi:10.1177/1745691610383505 · Cited by 186
Hannon, E. J., Gorrie-Stone, T. J., Smart, M., Burrage, J., Hughes, A., Bao, Y., Meena Kumari, B., Schalkwyk, L. C., & Mill, J. S. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.09.007 · Cited by 191
Dempfle, A., Scherag, A., Hein, R., Beckmann, L., Chang-Claude, J. C., & Schäfer, H. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.106 · Cited by 185
Mendelian randomization: use of genetics to enable causal inference in observational studies
Verduijn, M., Siegerink, B., Jager, K. J., Zoccali, C., & Dekker, F. W. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq098 · Cited by 191
Genetics, race, ethnicity, and health
Pearce, N. E., Foliaki, S., Sporle, A. A., & Cunningham, C. W. (2004) · BMJ · doi:10.1136/bmj.328.7447.1070 · Cited by 190
Nordestgaard, A. T., Thomsen, M., & Nordestgaard, B. G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv083 · Cited by 189
Presson, A. P., Sobel, E. M., Papp, J. C., Suarez, C., Whistler, T., Rajeevan, M. S., Vernon, S. D., & Horvath, S. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-95 · Cited by 189
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
Würtz, P., Wang, Q., Soininen, P., Kangas, A. J., Fatemifar, G., Tynkkynen, T., Tiainen, M., Perola, M., Tillin, T., Hughes, A. D., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.060 · Cited by 188
Zhao, Q., Chen, Y., Wang, J., & Small, D. S. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz142 · Cited by 188
Stroke genetics: discovery, biology, and clinical applications
Dichgans, M., Pulit, S. L., & Rosand, J. M. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30043-2 · Cited by 187
Perry, B. I., Upthegrove, R., Kappelmann, N., Jones, P. B., Burgess, S., & Khandaker, G. M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.07.009 · Cited by 187
Taylor, A. E., Fluharty, M. E., Bjørngaard, J. H., Gabrielsen, M. E., Skorpen, F., Marioni, R. E., Campbell, A., Engmann, J., Mirza, S. S., Loukola, A., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006141 · Cited by 187
Balduzzi, A., Valsecchi, M. G., UDERZO, C., Lorenzo, P. D., Klingebiel, T. E., Peters, C., Starý, J., Felice, M. S., Magyarosy, E., Conter, V., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66998-x · Cited by 186
Borges, M. C., Haycock, P., Zheng, J., Hemani, G., Holmes, M. V., Smith, G. D., Hingorani, A. D., & Lawlor, D. A. (2022) · BMC Medicine · doi:10.1186/s12916-022-02399-w · Cited by 180
Rosoff, D. B., Smith, G. D., & Lohoff, F. W. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3554 · Cited by 186
Genome-wide analysis identifies molecular systems and 149 genetic loci associated with income
Hill, W. D., Davies, N. M., Ritchie, S. J., Skene, N., Bryois, J., Bell, S., Angelantonio, E. D., Roberts, D. J., Shen, X., Davies, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13585-5 · Cited by 186
Lang, I., Guralnik, J. M., Wallace, R. B., & Melzer, D. R. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.01007.x · Cited by 189
Alcohol Consumption and Cardiovascular Disease
Larsson, S. C., Burgess, S., Mason, A. M., & Michaëlsson, K. (2020) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002814 · Cited by 189
Holmes, M. V., Richardson, T. G., Ference, B. A., Davies, N. M., & Davey Smith, G. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00493-1 · Cited by 184
Corbin, L. J., Richmond, R. C., Wade, K. H., Burgess, S., Bowden, J., Smith, G. D., & Timpson, N. J. (2016) · Diabetes · doi:10.2337/db16-0418 · Cited by 184
Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study
Afzal, S., Brøndum-Jacobsen, P., Bojesen, S. E., & Nordestgaard, B. G. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70200-6 · Cited by 190
Power and sample size calculations for Mendelian randomization studies using one genetic instrument
Freeman, G., Cowling, B. J., & Schooling, C. M. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt110 · Cited by 184
Wang, Q., Holmes, M. V., Smith, G. D., & Ala‐Korpela, M. (2017) · Diabetes Care · doi:10.2337/dc17-1642 · Cited by 182
Weischer, M., Nordestgaard, B. G., Pharoah, P. D. P., Bolla, M. K., Nevanlinna, H. A., Veer, L. J. V., García‐Closas, M., Hopper, J. L., Hall, P. N., Andrulis, I. L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7336 · Cited by 184
How many genes underlie the occurrence of common complex diseases in the population?
Yang, Q., Khoury, M. J., Friedman, J. M., Little, J., & Flanders, W. D. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi130 · Cited by 182
Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates
Rees, J. M. B., Wood, A., Dudbridge, F., & Burgess, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222362 · Cited by 177
Contextualizing selection bias in Mendelian randomization: how bad is it likely to be?
Gkatzionis, A., & Burgess, S. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyy202 · Cited by 182
Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study
Ni, J., Xu, Q., Yan, S., Han, B., Zhang, H., Wei, X., Feng, G.-J., Zhao, M., Pei, Y., & Zhang, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.737197 · Cited by 184
Lawlor, D. A., Timpson, N. J., Harbord, R. M., Leary, S. D., Ness, A., McCarthy, M. I., Frayling, T. M., Hattersley, A. T., & Smith, G. D. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050033 · Cited by 182
Thrift, A. P., Shaheen, N. J., Gammon, M. D., Bernstein, L., Reid, B. J., Onstad, L., Risch, H. A., Liu, G., Bird, N. C., Wu, A. H., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju252 · Cited by 179
Deep Learning of the Retina Enables Phenome- and Genome-Wide Analyses of the Microvasculature
Zekavat, S. M., Raghu, V. K., Trinder, M., Ye, Y., Koyama, S., Honigberg, M. C., Yu, Z., Pampana, A., Urbut, S., Haidermota, S., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.057709 · Cited by 181
Benn, M., Nordestgaard, B. G., Frikke-Schmidt, R., & Tybjærg-Hansen, A. (2017) · BMJ · doi:10.1136/bmj.j1648 · Cited by 178
Koletzko, B. V., Lattka, E., Kunze, S., Illig, T., & Steer, C. D. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.006189 · Cited by 179
Dai, Q., Shrubsole, M. J., Ness, R. M., Schlundt, D. G., Cai, Q., Smalley, W. E., Li, M., Shyr, Y., & Zheng, W. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.743 · Cited by 178
Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?
Li, N., Fu, J., Koonen, D. P. Y., Kuivenhoven, J. A., Snieder, H., & Hofker, M. H. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.013 · Cited by 179
Beynon, R. A., Lang, S., Schimansky, S., Penfold, C. M., Waylen, A. E., Thomas, S. J., Pawlita, M., Waterboer, T., Martin, R. M., May, M., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31416 · Cited by 174
Causal Inference in Developmental Origins of Health and Disease (DOHaD) Research
Gage, S. H., Munafò, M. R., & Davey Smith, G. (2016) · Annual Review of Psychology · doi:10.1146/annurev-psych-122414-033352 · Cited by 173
Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study
Pichler, I., Del Greco M., F., Gögele, M., Lill, C. M., Bertram, L., Do, C. B., Eriksson, N., Foroud, T., Myers, R. H., PD GWAS Consortium, et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001462 · Cited by 173
“Genes are randomly allocated at conception, so that genetic effects on the intermediate phenotype cannot be affected by classical confounding, such as lifestyle factors, or reverse causation, as in the situation where the phenotype level is influenced by the presence of the disease [8].”
BackgroundInfluentialLangley, K., Heron, J., Smith, G. D., & Thapar, A. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr510 · Cited by 173
Zhou, W., Liu, G., Hung, R. J., Haycock, P. C., Aldrich, M. C., Andrew, A. S., Arnold, S. M., Bickeböller, H., Bojesen, S. E., Brennan, P., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33292 · Cited by 172
Insight into the nature of the CRP–coronary event association using Mendelian randomization
Casas, J. P., Shah, T., Cooper, J. A., Hawe, E., McMahon, A. D., Gaffney, D., Packard, C. J., O’Reilly, D. S. J., Juhan-Vague, I., Yudkin, J. S., et al. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl041 · Cited by 172
Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study
Thomsen, M., Varbo, A., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.219881 · Cited by 171
Varbo, A., Benn, M., Smith, G. D., Timpson, N. J., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2014) · Circulation Research · doi:10.1161/circresaha.116.304846 · Cited by 171
Jaffee, S. R., Strait, L., & Odgers, C. L. (2011) · Psychological Bulletin · doi:10.1037/a0026020 · Cited by 185
Li, X., Chan, J. S. K., Guan, B., Peng, S., Wu, X., Lu, X., Zhou, J., Hui, J. M. H., Lee, Y. H. A., Satti, D. I., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01658-7 · Cited by 176
Genetics of Multiple Sclerosis: An Overview and New DirectionsPreprint
Patsopoulos, N. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028951 · Cited by 188
Role of obesity in smoking behaviour: Mendelian randomisation study in UK Biobank
Carreras‐Torres, R., Johansson, M., Haycock, P., Relton, C. L., Smith, G. D., Brennan, P., & Martin, R. M. (2018) · BMJ · doi:10.1136/bmj.k1767 · Cited by 173
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study
Dimitrakopoulou, V., Tsilidis, K. K., Haycock, P., Dimou, N. L., Al-Dabhani, K. M., Martin, R. M., Lewis, S. J., Gunter, M. J., Mondul, A. M., Shui, I. M., et al. (2017) · BMJ · doi:10.1136/bmj.j4761 · Cited by 168
Richmond, R. C., Davey Smith, G., Ness, A. R., den Hoed, M., McMahon, G., & Timpson, N. J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001618 · Cited by 167
Periodontitis and Systemic Disease: Association or Causality?
Winning, L., & Linden, G. J. (2017) · Current Oral Health Reports · doi:10.1007/s40496-017-0121-7 · Cited by 181
Taylor, D. L., Jackson, A., Narisu, N., Hemani, G., Erdos, M. R., Chines, P. S., Swift, A. J., Idol, J., Didion, J. P., Welch, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814263116 · Cited by 159
Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis
Narula, S., Yusuf, S., Chong, M., Ramasundarahettige, C. F., Rangarajan, S., Bangdiwala, S. I., van Eickels, M., Leineweber, K., Wu, A., Pigeyre, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31964-4 · Cited by 169
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study
Bull, C. J., Bell, J. A., Murphy, N., Sanderson, E. C. M., Smith, G. D., Timpson, N. J., Banbury, B. L., Albanes, D., Berndt, S. I., Bezieau, S., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01855-9 · Cited by 174
Taylor, A. E., Davies, N. M., Ware, J. J., VanderWeele, T., Smith, G. D., & Munafò, M. R. (2014) · Economics & Human Biology · doi:10.1016/j.ehb.2013.12.002 · Cited by 166
Linsel‐Nitschke, P., Götz, A., Erdmann, J., Brænne, I., Braund, P. S., Hengstenberg, C., Stark, K. J., Fischer, M., Schreiber, S., Mokhtari, N. E. E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002986 · Cited by 168
Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study
Nazarzadeh, M., Pinho-Gomes, A.-C., Bidel, Z., Dehghan, A., Canoy, D., Hassaine, A., Ayala Solares, J. R., Salimi-Khorshidi, G., Smith, G. D., Otto, C. M., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa070 · Cited by 163
Thomas, D. C. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103619 · Cited by 164
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis
Bandrés‐Ciga, S., Noyce, A. J., Hemani, G., Nicolas, A., Calvo, A., Mora, G., Tienari, P., Stone, D. J., Nalls, M. A., Singleton, A., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25431 · Cited by 172
The metabolomics of human aging: Advances, challenges, and opportunities
Panyard, D. J., Yu, B., & Snyder, M. P. (2022) · Science Advances · doi:10.1126/sciadv.add6155 · Cited by 159
Genetic predictors of participation in optional components of UK Biobank
Tyrrell, J., Zheng, J., Beaumont, R., Hinton, K., Richardson, T. G., Wood, A. R., Davey Smith, G., Frayling, T. M., & Tilling, K. (2021) · Nature Communications · doi:10.1038/s41467-021-21073-y · Cited by 162
HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study
Haase, C. L., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2015) · Diabetes · doi:10.2337/db14-1603 · Cited by 162
The heritability of self-control: A meta-analysis
Willems, Y. E., Boesen, N., Li, J., Finkenauer, C., & Bartels, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.02.012 · Cited by 190
Schnabel, R. B., Larson, M. G., Dupuis, J., Lunetta, K. L., Lipinska, I., Meigs, J. B., Yin, X., Rong, J., Vita, J. A., Newton‐Cheh, C., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.105668 · Cited by 160
Association between frailty and depression: A bidirectional Mendelian randomization study
Deng, M., Liu, F., Liang, Y., Wang, K., Nie, J., & Liu, J. (2023) · Science Advances · doi:10.1126/sciadv.adi3902 · Cited by 163
Emerging risk factors and markers of chronic kidney disease progression
Kronenberg, F. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.173 · Cited by 166
Surprises from genetic analyses of lipid risk factors for atherosclerosis
Musunuru, K., & Kathiresan, S. (2016) · Circulation Research · doi:10.1161/circresaha.115.306398 · Cited by 159
Heid, I. M., Henneman, P., Hicks, A. A., Coassin, S., Winkler, T. W., Aulchenko, Y. S., Fuchsberger, C., Song, K. S., Hivert, M., Waterworth, D. M., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.035 · Cited by 159
Cystatin C and Cardiovascular Disease
van der Laan, S. W., Fall, T., Soumaré, A., Teumer, A., Sedaghat, S., Baumert, J., Zabaneh, D., van Setten, J., Išgum, I., Galesloot, T. E., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.092 · Cited by 173
Within family Mendelian randomization studies
Davies, N. M., Howe, L. J., Brumpton, B., Havdahl, A., Evans, D. M., & Davey Smith, G. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz204 · Cited by 158
Bolton, J. L., Hayward, C., Direk, N., Lewis, J. G., Hammond, G. L., Hill, L. A., Anderson, A., Huffman, J. E., Wilson, J. F., Campbell, H. J., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004474 · Cited by 157
Burgess, S., Mason, A. M., Grant, A. J., Slob, E. A. W., Gkatzionis, A., Zuber, V., Patel, A. R., Tian, H., Liu, C., Haynes, W. G., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.12.017 · Cited by 157
Statistical methods for cis‐Mendelian randomization with two‐sample summary‐level data
Gkatzionis, A., Burgess, S., & Newcombe, P. J. (2022) · Genetic Epidemiology · doi:10.1002/gepi.22506 · Cited by 159
Causal associations between modifiable risk factors and the Alzheimer's phenome
Andrews, S. J., Fulton‐Howard, B., O'Reilly, P., Marcora, E., Goate, A. M., & collaborators of the Alzheimer's Disease Genetics Consortium (2021) · Annals of Neurology · doi:10.1002/ana.25918 · Cited by 156
McKay, J. A., Groom, A., Potter, C., Coneyworth, L. J., Ford, D., Mathers, J. C., & Relton, C. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033290 · Cited by 161
Hanley, B., Dijane, J., Fewtrell, M. S., Grynberg, A., Hummel, S., Junien, C., Koletzko, B. V., Lewis, S. J., Renz, H. E., Symonds, M. E., et al. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003338 · Cited by 165
Burgess, S., & Smith, G. D. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.03.042 · Cited by 155
van Kippersluis, H., & Rietveld, C. A. (2017) · Econometrics Journal · doi:10.1111/ectj.12113 · Cited by 146
Zhang, M., Chen, J., Yin, Z., Wang, L., & Peng, L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01759-z · Cited by 159
Richmond, R. C., Anderson, E. L., Dashti, H. S., Jones, S. E., Lane, J. M., Strand, L. B., Brumpton, B. M., Rutter, M. K., Wood, A. R., Straíf, K., et al. (2019) · BMJ · doi:10.1136/bmj.l2327 · Cited by 156
Broadbent, J. R., Foley, C. N., Grant, A. J., Mason, A. M., Staley, J. R., & Burgess, S. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16374.2 · Cited by 148
Metadata
- Authors
- Davey Smith, G., & Ebrahim, S.
- ORCID
- Ebrahim, Shah
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02
- Volume
- 32
- Issue
- 1
- Pages
- 1-22
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2106036991
- Cited by
- 5,882
- References
- 179
- Citations by year
- 2026: 333 · 2025: 673 · 2024: 1162 · 2023: 681 · 2022: 453 · 2021: 442 · 2020: 353 · 2019: 235 · 2018: 201 · 2017: 157 · 2016: 163 · 2015: 118 · 2014: 115 · 2013: 94 · 2012: 101
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- Mendelian randomization, genetic epidemiology, environmental factors in disease, causal inference, confounding, reverse causality, linkage disequilibrium, canalization, genetic polymorphism, genetic testing, public health genetics, disease prevention, Human Genome Project, pathogenesis, cancer genetics
- MeSH terms
- Animals, Disease, Environmental Exposure, Genotype, Humans, Polymorphism, Genetic, Molecular Epidemiology, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
